Delivery Order SPE2DB24D1034-SPE2DB25FWDC2
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,347.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp. for the supply of 150 mL bottles of the pharmaceutical product Quillivant XR 25 mg/5 mL suspension. This order is a part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
This is a $1,777.05 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 3, 2025. This appears to be a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication, and has a ceiling value of $1,577.04. The contract is a firm fixed-price Delivery Order with a completion date of January 22, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml containers, with a firm fixed price of $1,665.73 and a completion date of May 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The firm-fixed-price delivery order has a ceiling value of $1,846.75 and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,898.21, is a delivery order contract for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension. The contract has a firm fixed price pricing type and a completion date of March 25, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml bottle. The contract has a firm fixed price of $1,445.62 and a period of performance ending on April 8, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,310.10, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml containers. The contract is a firm fixed price delivery order with a period of performance through January 8, 2025. This award is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract is a delivery order with a firm fixed price of $1,524.36 and a completion date of June 7, 2023. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides medical supplies and pharmaceuticals to military and federal healthcare facilities. AmerisourceBergen holds a substantial...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract, valued at $1,933.39, is a delivery order with a firm fixed price. The ultimate completion date is February 26, 2025. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...